Furthermore, hyperglycemia induces a pro-inflammatory microenvironment characterized by elevated levels of systemic markers such as IL-6 and TNF-α, which correlate with disrupted bone turnover and increased skeletal fragility through mechanisms distinct from direct glucose-mediated effects (46). The gene discussed is IL6; the disease is Hyperglycemia.